# Waiel Awwad

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/waiel-awwad
Canonical HTML page: https://getbiobrief.com/entity/waiel-awwad

## Recent coverage (2 stories)

### Sudan Taps Indian Pharma for Manufacturing, Already 51% of Drug Imports
2026-07-28 23:57:28 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

As Sudan rebuilds, it is inviting Indian pharmaceutical companies to move beyond supply into local manufacturing and R&D, leveraging the existing 51% import market share to establish production hubs.
Full story: https://getbiobrief.com/story/sudan-india-pharma-manufacturing-investment

### Indian Pharma’s 51% Sudan Import Share Drives New Investment Drive
2026-07-11 21:02:09 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

India's 51% share of Sudan's pharmaceutical imports becomes a launchpad for direct investment, with local manufacturing and regulatory collaboration on the table as Sudan recovers from war. The roundtable signals a strategic expansion from generics exports to in-country pharma production.
Full story: https://getbiobrief.com/story/indian-pharma-sudan-investment-51-percent

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.